Pill Pushers: FDA Sets 2026 Fees for Drug Approvals
Published Date: 7/30/2025
Notice
Summary
The FDA is setting new fees for drug companies in fiscal year 2026 to help speed up the review of prescription drugs and biological products. If you’re a drug maker, expect some changes in how much you pay to get your products approved or stay on the market. These fees kick in starting October 1, 2025, so plan your budgets accordingly!
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in